Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Nicole, Weise"'
Autor:
Cassandra Duarte, Junxiao Hu, Benoit Beuselinck, Justine Panian, Nicole Weise, Nazli Dizman, Katharine A. Collier, Nityam Rathi, Haoran Li, Roy Elias, Nieves Martinez-Chanza, Tracy L. Rose, Lauren C. Harshman, Dharmesh Gopalakrishnan, Ulka Vaishampayan, Yousef Zakharia, Vivek Narayan, Benedito A. Carneiro, Anthony Mega, Nirmish Singla, Cheryl Meguid, Saby George, James Brugarolas, Neeraj Agarwal, Amir Mortazavi, Sumanta Pal, Rana R. McKay, Elaine T. Lam
Publikováno v:
EClinicalMedicine, Vol 60, Iss , Pp 102018- (2023)
Summary: Background: Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-year overall survival (OS) at 14%. Patients with mRCC to endocrine organs historically have prolonged OS. Pancreatic metastases are uncommon overall, wi
Externí odkaz:
https://doaj.org/article/153c01ff313644d0bf2fd30f76560d5d
Autor:
Chun, Loo Gan, Jiaming, Huang, Elizabeth, Pan, Wanling, Xie, Andrew L, Schmidt, Chris, Labaki, Luis, Meza, Gabrielle, Bouchard, Haoran, Li, Francesca, Jackson-Spence, Carla, Sánchez-Ruiz, Thomas, Powles, Shruti A, Kumar, Nicole, Weise, William A, Hall, Brent S, Rose, Benoit, Beuselinck, Cristina, Suarez, Sumanta K, Pal, Toni K, Choueiri, Daniel Y C, Heng, Rana R, McKay
Publikováno v:
European Urology Oncology. 6:204-211
There is a paucity of data on the safety of cabozantinib use in combination with radiotherapy.To report the practice patterns, safety, and efficacy of cabozantinib with radiotherapy in metastatic renal cell carcinoma (mRCC).An international multicent
Autor:
Pier Vitale Nuzzo, Elio Adib, Nicole Weise, Catherine Curran, Tyler Stewart, Dory Freeman, Amin H. Nassar, Sarah Abou Alaiwi, Ziad Bakouny, Bradley A. McGregor, Toni K. Choueiri, Rakesh K. Jain, Rana R. McKay, Guru Sonpavde
Publikováno v:
Clin Genitourin Cancer
In this multicenter retrospective study, we studied the impact of the concurrent use of renin-angiotensin system inhibitors (RASi) on the outcomes of 229 metastatic renal cell carcinoma (mRCC) patients treated with immune-checkpoint inhibitors (ICI).
Autor:
Kevin Hakimi, Ava Saidian, Justine Panian, Pedro Barata, Stephanie Berg, Steven Chang, Renee Saliby, Hannah Dzimitrowicz, Hamid Emamekhoo, Evan Gross, Deepak Kilari, Elaine Lam, Mimi Nguyen, Margaret Meagher, Grant Rauterkus, Vincent D'Andrea, Kendrick Yim, Sarah Psutka, Bicky Thapa, Nicole Weise, Tian Zhang, Rana McKay, Ithaar Derweesh
Publikováno v:
Journal of Urology. 209
Autor:
Elizabeth Pan, Justin Shaya, Lisa Madlensky, J. Michael Randall, Juan Javier-Desloges, Frederick E. Millard, Brent Rose, J. Kellogg Parsons, Sarah M. Nielsen, Kathryn E. Hatchell, Edward D. Esplin, Robert L. Nussbaum, Nicole Weise, James Murphy, Maria Elena Martinez, Rana R. McKay
Publikováno v:
Prostate Cancer and Prostatic Diseases. 25:561-567
Autor:
Rana R. McKay, Nicole Weise, Justin Shaya, Heather H. Cheng, Juan Javier-Desloges, Lisa Madlensky
Publikováno v:
Prostate Cancer and Prostatic Diseases
Prostate cancer and prostatic diseases, vol 25, iss 3
Prostate cancer and prostatic diseases, vol 25, iss 3
Germline testing is becoming increasingly relevant in prostate cancer (PCa) screening, prognosis, and management. A subset of patients with PCa harbor pathogenic/likely pathogenic variants (P/LPVs) in genes mediating DNA-repair processes, and these P
Autor:
Elizabeth, Pan, Justin, Shaya, Lisa, Madlensky, J Michael, Randall, Juan, Javier-Desloges, Frederick E, Millard, Brent, Rose, J Kellogg, Parsons, Sarah M, Nielsen, Kathryn E, Hatchell, Edward D, Esplin, Robert L, Nussbaum, Nicole, Weise, James, Murphy, Maria Elena, Martinez, Rana R, McKay
Publikováno v:
Prostate cancer and prostatic diseases. 25(3)
Little is known about the true rate of pathogenic (P)/likely pathogenic (LP) germline alterations in Hispanic men with prostate cancer as most studies analyzing the prevalence of P/LP germline alterations were performed in a largely non-Hispanic whit
Autor:
Deepak Kilari, Aniko Szabo, Pooja Ghatalia, Tracy L Rose, Huaying Dong, Nicole Weise, Tony Z. Zhuang, Abdurahman Alloghbi, Rohit K. Jain, Ajjai Shivaram Alva, Abhishek Tripathi, Arnab Basu, Nancy B. Davis, James Brundage, Hamid Emamekhoo, Yousef Zakharia, Vadim S Koshkin, Mehmet Asim Bilen, Elisabeth I. Heath, Rana R. McKay
Publikováno v:
Journal of Clinical Oncology. 40:4545-4545
4545 Background: Despite recent advances in the treatment of clear cell RCC, there is a paucity of data to guide management of nccRCC due to the heterogeneity and rarity of these tumors. The clinical activity of combination therapies (including IO-IO
Autor:
Xun Lin, Rana R. McKay, Nicole Weise, Angelo Cabal, Justine Panian, Justin Shaya, Ithaar Derweesh
Publikováno v:
Clinical genitourinary cancer. 19(6)
Pancreatic metastases (PM) are rare in renal cell carcinoma. It has been suggested that patients with metastases to the pancreas have a more favorable prognosis, but little is known about the long-term outcomes with systemic therapy. We sought to und
Autor:
Catherine Curran, Amin Nassar, S. Abou Alaiwi, Elio Adib, Guru Sonpavde, Pier Vitale Nuzzo, Tyler F. Stewart, Bradley Alexander McGregor, Ziad Bakouny, Nicole Weise, Rana R. McKay, Dory Freeman, Toni K. Choueiri, Rakesh K. Jain
Publikováno v:
Annals of Oncology. 32:S702-S703